title: Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan.
abstract: To assess whether hepatitis C virus infection was a risk factor for the development of non-alcoholic liver cirrhosis, antibody to hepatitis C virus (anti-HCV; detected by a second generation HCV enzyme immunoassay), hepatitis B surface antigen (HBsAg; detected by radioimmunoassay) were tested in 150 cirrhotics and 150 sex-matched and age-matched healthy controls. The prevalence of anti-HCV and HBsAg in cirrhotics was higher than in controls (22.0%, 73.3% vs. 2%, 18.7%; P = 0.001). The prevalence of anti-HCV in HBsAg-negative cirrhotics (45.0%) was higher than that in HBsAg-positive patients (13.6%; P = 0.001). Both the anti-HCV and carriage of HBsAg were associated significantly with liver cirrhosis, showing odds ratio of 12.0 for HBsAg carriers and 13.8 for patients with anti-HCV. Compared with those without HBsAg and anti-HCV, there was a significantly positive linear trend for developing cirrhosis with the presence of HBsAg alone (odds ratio = 19.9), anti-HCV alone (odds ratio = 49.0), and those positive for HBsAg and anti-HCV (odds ratio = 81.8) (P = 0.00001). The population-attributable risk for developing liver cirrhosis was estimated as 10.8% for anti-HCV alone, 55.2% for HBsAg alone, and 9.4% for both anti-HCV and HBsAg in southern Taiwan. In conclusion, this study shows that hepatitis B and C virus infection act independently and synergistically in the development of non-alcoholic liver cirrhosis among Chinese in Taiwan.
authors.affiliation: Department of Internal Medicine, Kaohsiung Medical College, Taiwan, Republic of China.
authors.forename: J F
authors.initials: JF
authors.lastname: Tsai
authors.forename: W Y
authors.initials: WY
authors.lastname: Chang
authors.forename: J E
authors.initials: JE
authors.lastname: Jeng
authors.forename: M S
authors.initials: MS
authors.lastname: Ho
authors.forename: L Y
authors.initials: LY
authors.lastname: Wang
authors.forename: M Y
authors.initials: MY
authors.lastname: Hsieh
authors.forename: S C
authors.initials: SC
authors.lastname: Chen
authors.forename: W L
authors.initials: WL
authors.lastname: Chuang
authors.forename: Z Y
authors.initials: ZY
authors.lastname: Lin
authors.forename: J H
authors.initials: JH
authors.lastname: Tsai
mesh_terms: D000367:Age Factors; D000368:Aged; D002908:Chronic Disease; D005260:Female; D016174:Hepacivirus / Q000276:immunology; D006508:Hepatitis Antibodies / Q000097:blood; D006509:Hepatitis B / Q000150:complications; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006526:Hepatitis C / Q000150:complications* / Q000453:epidemiology; D018937:Hepatitis C Antibodies; D006801:Humans; D007124:Immunoenzyme Techniques; D008103:Liver Cirrhosis / Q000209:etiology*; D008297:Male; D016555:Matched-Pair Analysis; D008875:Middle Aged; D012307:Risk Factors; D012737:Sex Factors; D013624:Taiwan / Q000453:epidemiology
chemical_list: D006508:Hepatitis Antibodies; D006514:Hepatitis B Surface Antigens; D018937:Hepatitis C Antibodies